tetano
Editor, Senior Moderator
Thromb J
. 2023 Jan 2;21(1):1.
doi: 10.1186/s12959-022-00436-5.
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time
Ruben Siedlarczyk Nogueira[SUP] 1 [/SUP], Bruno Ramos Salu[SUP] 1 [/SUP], Vinícius Goulart Nardelli[SUP] 1 [/SUP], Camila Ramalho Bonturi[SUP] 1 [/SUP], Marina Rodrigues Pereira[SUP] 2 [/SUP], Francisco Humberto de Abreu Maffei[SUP] 3 [/SUP], Eduardo Maffud Cilli[SUP] 2 [/SUP], Maria Luiza Vilela Oliva[SUP] 4 [/SUP]
Affiliations
Abstract
Background: (p-BthTX-I)[SUB]2[/SUB] K, a dimeric analog peptide derived from the C-terminal region of phospholipase A2-like bothropstoxin-I (p-BthTX-I), is resistant to plasma proteolysis and inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains with weak cytotoxic effects. Complications of SARS-CoV-2 infection include vascular problems and increased risk of thrombosis; therefore, studies to identify new drugs for treating SARS-CoV-2 infections that also inhibit thrombosis and minimize the risk of bleeding are required.
Objectives: To determine whether (p-BthTX-I)[SUB]2[/SUB] K affects the hemostatic system.
Methods: Platelet aggregation was induced by collagen, arachidonic acid, and adenosine diphosphate (ADP) in the Chronolog Lumi-aggregometer. The coagulation activity was evaluated by determining activated partial thromboplastin clotting time (aPTT) and prothrombin time (PT) with (p-BthTX-I)[SUB]2[/SUB] K (5.0-434.5 µg) or 0.9% NaCl. Arterial thrombosis was induced with a 540 nm laser and 3.5-20 mg kg[SUP]- 1[/SUP] Rose Bengal in the carotid artery of male C57BL/6J mice using (p-BthTX-I)[SUB]2[/SUB] K. Bleeding time was determined in mouse tails immersed in saline at 37 °C after (p-BthTX-I)[SUB]2[/SUB] K (4.0 mg/kg and 8.0 mg/kg) or saline administration.
Results: (p-BthTX-I)[SUB]2[/SUB] K prolonged the aPTT and PT by blocking kallikrein and FXa-like activities. Moreover, (p-BthTX-I)[SUB]2[/SUB] K inhibited ADP-, collagen-, and arachidonic acid-induced platelet aggregation in a dose-dependent manner. Further, low concentrations of (p-BthTX-I)[SUB]2[/SUB] K extended the time to artery occlusion by the formed thrombus. However, (p-BthTX-I)[SUB]2[/SUB] K did not prolong the bleeding time in the mouse model of arterial thrombosis.
Conclusion: These results demonstrate the antithrombotic activity of the peptide (p-BthTX-I)[SUB]2[/SUB] K possibly by kallikrein inhibition, suggesting its strong biotechnological potential.
Keywords: Bleeding; COVID-19; Cysteine-protease; Papain-like protease; Platelets; SARS-CoV-2; Thrombosis.
. 2023 Jan 2;21(1):1.
doi: 10.1186/s12959-022-00436-5.
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time
Ruben Siedlarczyk Nogueira[SUP] 1 [/SUP], Bruno Ramos Salu[SUP] 1 [/SUP], Vinícius Goulart Nardelli[SUP] 1 [/SUP], Camila Ramalho Bonturi[SUP] 1 [/SUP], Marina Rodrigues Pereira[SUP] 2 [/SUP], Francisco Humberto de Abreu Maffei[SUP] 3 [/SUP], Eduardo Maffud Cilli[SUP] 2 [/SUP], Maria Luiza Vilela Oliva[SUP] 4 [/SUP]
Affiliations
- PMID: 36593467
- DOI: 10.1186/s12959-022-00436-5
Abstract
Background: (p-BthTX-I)[SUB]2[/SUB] K, a dimeric analog peptide derived from the C-terminal region of phospholipase A2-like bothropstoxin-I (p-BthTX-I), is resistant to plasma proteolysis and inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains with weak cytotoxic effects. Complications of SARS-CoV-2 infection include vascular problems and increased risk of thrombosis; therefore, studies to identify new drugs for treating SARS-CoV-2 infections that also inhibit thrombosis and minimize the risk of bleeding are required.
Objectives: To determine whether (p-BthTX-I)[SUB]2[/SUB] K affects the hemostatic system.
Methods: Platelet aggregation was induced by collagen, arachidonic acid, and adenosine diphosphate (ADP) in the Chronolog Lumi-aggregometer. The coagulation activity was evaluated by determining activated partial thromboplastin clotting time (aPTT) and prothrombin time (PT) with (p-BthTX-I)[SUB]2[/SUB] K (5.0-434.5 µg) or 0.9% NaCl. Arterial thrombosis was induced with a 540 nm laser and 3.5-20 mg kg[SUP]- 1[/SUP] Rose Bengal in the carotid artery of male C57BL/6J mice using (p-BthTX-I)[SUB]2[/SUB] K. Bleeding time was determined in mouse tails immersed in saline at 37 °C after (p-BthTX-I)[SUB]2[/SUB] K (4.0 mg/kg and 8.0 mg/kg) or saline administration.
Results: (p-BthTX-I)[SUB]2[/SUB] K prolonged the aPTT and PT by blocking kallikrein and FXa-like activities. Moreover, (p-BthTX-I)[SUB]2[/SUB] K inhibited ADP-, collagen-, and arachidonic acid-induced platelet aggregation in a dose-dependent manner. Further, low concentrations of (p-BthTX-I)[SUB]2[/SUB] K extended the time to artery occlusion by the formed thrombus. However, (p-BthTX-I)[SUB]2[/SUB] K did not prolong the bleeding time in the mouse model of arterial thrombosis.
Conclusion: These results demonstrate the antithrombotic activity of the peptide (p-BthTX-I)[SUB]2[/SUB] K possibly by kallikrein inhibition, suggesting its strong biotechnological potential.
Keywords: Bleeding; COVID-19; Cysteine-protease; Papain-like protease; Platelets; SARS-CoV-2; Thrombosis.